# GSK Consumer Health Recalls Five Excedrin Brands Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning
> **CPSC recall** · 2020-12-23 · 21057 · 1 injuries reported
## Recall
- **Number:** 21057
- **Date:** 2020-12-23
- **Injuries reported:** 1
## Products

Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets

## Hazards

Some of the bottles containing the over-the-counter drug can have a hole in the bottom. If there is a hole, children could access and swallow the contents, posing a risk of poisoning. These products contain the substances aspirin and acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA).

## Remedies

Refund

## Manufacturer(s)

GSK Consumer Healthcare, of Warren, N.J.

## Retailer(s)

Pharmacies, department stores, grocery stores, and hypermarkets nationwide and online from March 2018 through September 2020 for between $7 and $18.

## Country of manufacture

United States

## Description

This recall involves 50, 80, 100, 125, 200, 250 and 300-count bottles of Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets. The bottles are plastic with a child-resistant closure. For a full list of the recalled products, visit www.excedrin.com/products/discontinued.

## Source
- [CPSC recall page](https://www.cpsc.gov/Recalls/2021/GSK-Consumer-Health-Recalls-Five-Excedrin-Brands-Due-to-Failure-to-Meet-Child-Resistant-Packaging-Requirement-Risk-of-Poisoning)
---
*AI Analytics · CC0 1.0*